N. SAI KIRAN; H.PARAMESHWAR; A.V. JITHAN. Method Development and its Validation for Antineoplastic Agents (Ruxolitinib) by RP-HPLC. International Journal of Allied Medical Sciences and Clinical Research, [S. l.], v. 10, n. 2, p. 268–273, 2022. DOI: 10.61096/ijamscr.v10.iss2.2022.268-273. Disponível em: https://ijamscr.com/ijamscr/article/view/1215. Acesso em: 28 apr. 2024.